256 related articles for article (PubMed ID: 2781511)
1. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
2. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
von Kries R; Stannigel H; Göbel U
Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
[TBL] [Abstract][Full Text] [Related]
4. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
5. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Gotoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
[TBL] [Abstract][Full Text] [Related]
6. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
7. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
Kessler CM; Tang Z; Jacobs HM; Szymanski LM
Blood; 1997 Jun; 89(12):4393-401. PubMed ID: 9192763
[TBL] [Abstract][Full Text] [Related]
8. Treatment of DIC with antithrombin III concentrates.
Sakata Y; Yoshida N; Matsuda M; Aoki N
Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
10. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
Carmassi F; Morale M; De Negri F; Carrai M
J Mol Med (Berl); 1995 Feb; 73(2):89-93. PubMed ID: 7627635
[TBL] [Abstract][Full Text] [Related]
11. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
Jespersen J; Rasmussen NR; Sidelmann J
Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
[No Abstract] [Full Text] [Related]
12. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III patterns in disseminated intravascular coagulation.
Bick RL; Bick MD; Fekete LF
Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
[TBL] [Abstract][Full Text] [Related]
14. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
Kobayashi H; Kawai S; Oshitani H; Tamakuma S; Hayasaka H; Akiyama M; Nakamura T; Hashimoto I; Sawada Y; Takebe K
Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
[No Abstract] [Full Text] [Related]
15. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
[TBL] [Abstract][Full Text] [Related]
16. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
17. [Therapy with antithrombin III concentrate].
Vinazzer H
Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
[No Abstract] [Full Text] [Related]
18. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
Sobczyk J; Swietliński J; Podleśny-Owsińska T
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
[No Abstract] [Full Text] [Related]
19. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
